• The company has scheduled an Analyst/Investor Meeting to be held on Thursday, November 19, 2026.
  • The event is part of the CLSA Financials Tour and will be conducted in-person in Chennai.
  • The meeting timing is scheduled from 11:30 AM to 12:30 PM IST.
  • The disclosure explicitly states that the meeting is "subject to changes that may happen due to exigencies on the part of Analysts/Investors of the Company."
  • The purpose of the meeting is not explicitly stated beyond being a meeting with Analysts/Institutional Investors.
  • No specific management participants or their designations are mentioned in the disclosure.
  • A presentation for the meeting is available at the provided URL: https://d28c6jni2fmamz.cloudfront.net/ECPH1Q2FY27_f8e43c260a.pdf.
  • The disclosure will also be made available on the Company's website at www.starhealth.in.
  • The document is filed in compliance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Additional Notes Section

  • The document is a formal intimation letter addressed to both BSE Limited and National Stock Exchange of India Limited.
  • The reference number for the disclosure is SHAI/B & S/SE/156/2026-27.
  • The letter is signed by Jayashree Sethuraman, Company Secretary & Compliance Officer.
  • No financial data, performance figures, guidance, or strategic updates were disclosed in this announcement.
  • The document contains standard compliance language but does not include an explicit statement about unpublished price sensitive information (UPSI).